RESEARCH – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2026-04-11

Phase I trial published in Nature: China’s novel base-editing therapy brings hope of cure for thalassemia patients

In a breakthrough for gene therapy, the international academic journal Nature has published a landmark clinical study detailing the successful use of a novel base-editing drug to treat β-thalassemia. Jointly conducted by ShanghaiTech University, the First Affiliated Hospital of Guangxi Medical University, Fudan University, and CorrectSequence Therapeutics, the early-stage clinical trial of the base-editing drug CS-101 injection reports that

PIER MARIA FORNASARI
2026-04-04

This Could Be Why COVID and Flu Are So Dangerous to the Elderly

University of California San Francisco study shows that aging connective tissue in the lungs brings on a catastrophic immune response in older people. lder adults are much more likely to become seriously ill from flu or COVID-19 because aging lung cells can drive extreme immune responses, according to a new study led by researchers at

No Comments InCovid-19 RESEARCH

PIER MARIA FORNASARI
2026-03-28

Surviving sepsis: New guidelines harness life saving evidence for treating adults

Updated recommendations include critical insights from research An international team of experts recently came together to update sepsis care guidelines for adults for the first time since 2021. The updates have profound implications for the management of sepsis, which is responsible for approximately 11 million deaths per year worldwide. Co-led by University of Michigan’s Hallie Prescott, M.D.,

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-03-22

Long Dismissed in Adult Health, the Thymus May Be Critical for Longevity and Cancer Treatment

Mass General Brigham researchers used artificial intelligence to analyze routine medical scans, uncovering how the thymus impacts aging, cardiovascular risk, cancer incidence, and response to immunotherapy. Two new studies from investigators at Mass General Brigham challenge a decades-old assumption that the thymus, an organ best known for its role in establishing immune function in childhood, becomes irrelevant

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-03-11

Study: Electrical stimulation can restore ability to move limbs, receive sensory feedback after spinal cord injury

In new results from a clinical trial, researchers show that electrical stimulation of the spinal cord can restore the muscle control and sensory feedback required for coordinated walking movements. The effects of spinal cord injuries are complex and multifaceted. People lose not only the ability to control the movement of their limbs, but also the

No Comments InRESEARCH

PIER MARIA FORNASARI
2026-03-05

Researchers develop beating, 3D‑printed heart model for surgical practice

Washington State University researchers have developed a 3D-printed model of the left side of the heart that contracts and beats, offering the chance for surgeons and medical students to rehearse important heart surgeries on a model that acts like the real thing. The WSU researchers, in fact, did a valve repair on their heart model, using ultrasound imaging

No Comments InRESEARCH

PIER MARIA FORNASARI
2026-03-02

From Longevity to Cancer: Understanding the Dual Nature of Polyamines

Study reveals how the same molecules that promote healthy aging can fuel cancer growth through distinct molecular pathways Polyamines, a group of naturally occurring molecules found in all living organisms, are essential for fundamental cellular processes, such as growth and differentiation. In recent years, these compounds (particularly spermidine) have gained attention as promising ‘geroprotectors’ that

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-03-01

New therapeutic strategy options form osteoporosis treatment

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate endpoint for fractures in phase 3 trials of investigational drugs in postmenopausal women with osteoporosis. The qualification was based on data generated by the

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-02-26

Study warns of nutritional risks of prolonged use of the drug omeprazole

Research conducted on rats reinforces the idea that proton pump inhibitors, which are widely used to treat stomach problems, can affect mineral absorption and compromise bone health. A study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) warns that the prolonged use of proton

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-02-25

High risk of readmission and death among heart failure patients

Almost half of patients admitted to hospital for acute heart failure in Europe are readmitted within a year, according to a new study led by researchers at Karolinska Institutet and published in the European Heart Journal. In addition, the risk of death remains high, especially for those with more severe heart failure. Heart failure is

No Comments InRESEARCH WELLNESS

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Category RESEARCH

Phase I trial published in Nature: China’s novel base-editing therapy brings hope of cure for thalassemia patients

This Could Be Why COVID and Flu Are So Dangerous to the Elderly

Surviving sepsis: New guidelines harness life saving evidence for treating adults

Long Dismissed in Adult Health, the Thymus May Be Critical for Longevity and Cancer Treatment

Study: Electrical stimulation can restore ability to move limbs, receive sensory feedback after spinal cord injury

Researchers develop beating, 3D‑printed heart model for surgical practice

From Longevity to Cancer: Understanding the Dual Nature of Polyamines

New therapeutic strategy options form osteoporosis treatment

Study warns of nutritional risks of prolonged use of the drug omeprazole

High risk of readmission and death among heart failure patients